Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

NNovaBridge Biosciences

EconomyAI buildoutMarket MapFundsWatchlist
Log in
N

NovaBridge Biosciences

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Fiscal Q4 2025Dec 31, 2025
Fiscal Q3 2025Sep 30, 2025
Fiscal Q4 2024Dec 31, 2024
Fiscal Q3 2024Sep 30, 2024
Fiscal Q4 2020Dec 31, 2020
Fiscal Q4 2019Dec 31, 2019
Money the company earns from selling products or services, before subtracting costs.
—————
Money left from sales after paying the direct costs of what the company sells.Formula: Revenue − cost of revenue
——
The costs of running the business beyond making or delivering its products, such as research, marketing, and office expenses.
+445.2% YoY-27.6% YoY——
Profit from the company’s main business, before taxes and income or costs outside those operations.Formula: Gross profit − operating expenses
-445.2% YoY+27.6% YoY——
Money earned or spent outside the main business, such as investment income and interest on debt.Formula: Non-operating income − non-operating expenses
-98.3% YoY——
Profit before income taxes are taken out.Formula: Operating income + net non-operating income + pre-tax adjustments
-571.9% YoY+66.7% YoY
The income tax cost counted against the period’s profit, including amounts payable now or later.
The profit left after all expenses and taxes. A negative number means the company lost money.Formula: Total income − total expenses
-571.9% YoY+66.7% YoY
Profit for each ordinary share during the reporting period.Formula: Earnings available to common shareholders ÷ weighted-average basic shares
-100.0% YoY————
Profit per share after counting potential extra shares from stock awards or convertible securities that would reduce it.Formula: Diluted earnings available to common shareholders ÷ weighted-average diluted shares
-100.0% YoY——